Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
about
The immune microenvironment of breast ductal carcinoma in situ.A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition.Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signalingCan pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasisThe Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.Identifying progression predictors of breast ductal carcinoma in situ.Prognostic immune-related gene models for breast cancer: a pooled analysis.The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival.Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management
P2860
Q33834968-D0FE5ABC-9666-4725-98AF-8BFB1A7DD3D6Q33835581-319C6893-5365-468A-8541-B15DBE2A0F13Q34298024-ADBBB721-9DE5-4169-AB44-8689DA093DFCQ35779345-1D242624-01DE-49CC-94B4-F689B151401DQ36605526-31536148-194A-4D2A-B70B-26894A8FD8C3Q36620907-09D1C9EE-700D-4092-84F5-6393BC3ADA82Q37695311-56387535-DB54-4E5B-AE3C-D3E1E85742A1Q38890318-60C23919-1F8E-4959-80A9-32A86DDB5D51Q39013710-CEF399D1-D87E-4D39-92D8-42716571ECB1Q42001306-E324DAAC-23A6-46C4-B05F-D5900A68FD68Q53720891-0B2C158B-FB99-4D6E-9525-FA8EA5ED8DA1Q54533459-41E740B4-A57C-4884-B933-4613C6171DECQ57106000-20B775B3-3B0F-4F08-B69B-A030163C40B2
P2860
Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Receptor tyrosine kinase signa ...... the adaptive immune response.
@en
type
label
Receptor tyrosine kinase signa ...... the adaptive immune response.
@en
prefLabel
Receptor tyrosine kinase signa ...... the adaptive immune response.
@en
P2093
P2860
P1433
P1476
Receptor tyrosine kinase signa ...... the adaptive immune response.
@en
P2093
Babette Schade
Ciriaco A Piccirillo
David Denardo
Donal J Brennan
Dongmei Zuo
Elton Rexhepaj
Josie Ursini-Siegel
Lisa M Coussens
Michael Hallett
P2860
P304
P356
10.1158/0008-5472.CAN-10-2229
P407
P577
2010-10-05T00:00:00Z